Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era

SIMPLE SUMMARY: The potential interference at the immune response level between COVID-19 and cancer therapy raises key clinical questions and points out scientific issues that need to be promptly addressed. Among the therapeutic strategies available in oncological clinics, major concerns are raised...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Burgaletto, Chiara, Brunetti, Oronzo, Munafò, Antonio, Bernardini, Renato, Silvestris, Nicola, Cantarella, Giuseppina, Argentiero, Antonella
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Opinion
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071446/
https://ncbi.nlm.nih.gov/pubmed/33921021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13081906
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items